Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives

SIMPLE SUMMARY: AML is a genetically heterogeneous disease with a median age of diagnosis between 60 and 70 years. Thus, many AML patients are not eligible for intensive chemotherapy. Often, the disease is accompanied by a poor prognosis due to high-risk genetic features or due to antecedent hematol...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Maximilian, Schnetzke, Ulf, Hochhaus, Andreas, Scholl, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616498/
https://www.ncbi.nlm.nih.gov/pubmed/34830877
http://dx.doi.org/10.3390/cancers13225722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616498/
https://www.ncbi.nlm.nih.gov/pubmed/34830877
http://dx.doi.org/10.3390/cancers13225722

Ejemplares similares